Form 8-K - Current report:
SEC Accession No. 0001193125-17-337360
Filing Date
2017-11-08
Accepted
2017-11-08 16:45:56
Documents
3
Period of Report
2017-11-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d467853d8k.htm 8-K 17785
2 EX-99.1 d467853dex991.htm EX-99.1 6287
3 GRAPHIC g467853g1108081545693.jpg GRAPHIC 3537
  Complete submission text file 0001193125-17-337360.txt   30324
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36544 | Film No.: 171187192
SIC: 2834 Pharmaceutical Preparations